An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinoma.

Givechian, Kevin B; Garner, Chad; Benz, Steve; Song, Bing; Rabizadeh, Shahrooz; Soon-Shiong, Patrick

Givechian, Kevin B; Garner, Chad; Benz, Steve; Song, Bing; Rabizadeh, Shahrooz; Soon-Shiong, Patrick.

Afiliación

Givechian KB; NantOmics LLC, Culver City, CA 90232, USA.
Garner C; NantHealth, Inc. NantWorks, Culver City, CA 90232, USA.
Benz S; NantOmics LLC, Culver City, CA 90232, USA.
Song B; NantOmics LLC, Culver City, CA 90232, USA.
Rabizadeh S; NantOmics LLC, Culver City, CA 90232, USA.
Soon-Shiong P; NantHealth, Inc. NantWorks, Culver City, CA 90232, USA.

Oncotarget ; 10(19): 1840-1849, 2019 Mar 05.

Article en En | MEDLINE | ID: mdl-30956762

Palabras clave

NSCLC; lung adenocarcinoma; lung squamous cell carcinoma; tumor immunology; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google